AGA presents cutting-edge research during DDW®

Advances highlight progress being made in the treatment and research of GI disorders

2012-05-21

(Press-News.org) San Diego, CA (May 18, 2012) — Clinicians, researchers and scientists from around the world will gather for Digestive Disease Week® (DDW) 2012, the largest and most prestigious gastroenterology meeting, from May 19-22, 2012, at the San Diego Convention Center, CA. DDW, the annual meeting of the American Gastroenterological Association (AGA) Institute, is jointly sponsored by the American Association for the Study of Liver Diseases, the AGA, the American Society for Gastrointestinal Endoscopy and the Society for Surgery of the Alimentary Tract.

AGA researchers will present exciting, cutting-edge data during the meeting that will help change the way physicians diagnose and treat gastrointestinal (GI) disorders. All data presented during DDW is embargoed until the beginning of the presentation or an official DDW press conference, whichever occurs first. A list of press conferences is available at www.ddw.org/press. All sessions will be held in the San Diego Convention Center unless otherwise noted.

AGA Late-Breaking Sessions Late-breaking abstract poster sessions will occur on May 21, 8 a.m.-5 p.m. PT, Halls C–G. In addition, on May 22, 8:30 a.m. PT, Room 20d, the AGA will feature its most impressive late-breaking abstracts, which include exciting data on:

Oral Methylnaltrexone for the Treatment of Opioid-Induced Constipation in Patients With Noncancer Pain (8:30 a.m. PT, Abstract #943a) Richard L. Rauck et al. Vedolizumab Induction Therapy for Ulcerative Colitis: Results of Gemini I, a Randomized, Placebo-Controlled, Double-Blind, Multicenter Phase 3 Trial (8:45 a.m. PT, Abstract #943b) Brian G. Feagan et al. Accelerated Step-Care Therapy With Early Azathioprine (AZA) vs. Conventional Step-Care Therapy in Crohn's Disease: A Randomized Study (9 a.m. PT, Abstract #943c) Jacques Cosnes et al. A Phase 2/3 Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of Subcutaneous Golimumab Induction Therapy in Patients With Moderately to Severely Active Ulcerative Colitis: Pursuit SC (9:15 a.m. PT, Abstract #943d) William J. Sandborn et al. Mudelta Treatment Improves Bowel Movement Frequency and Urgency Episodes in Patients With Diarrhea-Predominant Irritable Bowel Syndrome: Results of a Phase 2 Clinical Trial (9:30 a.m. PT, Abstract #943e) Paul S. Covington et al. Tmc435 in HCV Genotype 1 Patients Who Have Failed Previous Pegylated Interferon/Ribavirin Treatment: Final Svr24 Results of the Aspire Trial (9:45 a.m. PT, Abstract #943f ) Fred Poordad et al.

Plenary Sessions During the Presidential Plenary Session, AGA Institute President, C. Richard Boland, MD, AGAF, will focus on the latest research and clinical advances in the field of gastroenterology. Two additional plenary sessions feature noteworthy clinical and basic science research presented at DDW.

The Presidential Plenary Session presentations (May 21, 10 a.m. PT, Room 20d) include:

The Future of Clinical Practice in Gastroenterology. John I. Allen, Minnesota Gastroenterology PA; University of Minnesota School of Medicine Medicine in the United Kingdom - Contrasts and Lessons From the National Health Service. Jonathan M. Rhodes, University of Liverpool Curing Chronic Viral Hepatitis - the New World of Antiviral Therapy. Jacqueline G. O'Leary, Liver Consultants of Texas GI Motility, Irritable Bowel Syndrome, and Women. Lin Chang, UCLA Division of Digestive Diseases The Future of Personalized Medicine - Reality vs Illusion. Anil K. Rustgi, University of Pennsylvania School of Medicine How Will We Prevent Colorectal Cancer in the Future? Dennis J. Ahnen, Denver VA Medical Center The Microbiome and Inflammation. Gary D. Wu, University of Pennsylvania School of Medicine Obesity, Diet and the Microbiome. Lee M. Kaplan, Massachusetts General Hospital The Future of IBD Therapy. William J. Sandborn, University of California, San Diego

The Basic Science Plenary Session presentations (May 20, 2:15 p.m. PT, Room 6e) include:

Heme Oxygenase-1 Maintains Intestinal Homeostasis Through Augmented Enteric Bacterial Clearance (2:20 p.m. PT, Abstract #514) Joseph C. Onyiah et al. Weight-Independent Changes in Gut Microbial Ecology Regulate Adiposity Following Roux-en-Y Gastric Bypass Surgery in Mice (2:35 p.m. PT, Abstract #515) Alice P. Liou et al. The Gut Microbiota At the Interface Between Mucosal Immunity and Host Metabolism (2:50 p.m. PT, Abstract #Sp502) Martin J. Blaser DCLK1 Labels a Multipotent and Residual Neural Crest-Derived Stem Cell in the Gut Epithelium and Enteric Nervous System (3:10 p.m. PT, Abstract #515a) Michael Quante et al. Cell-Autonomous ADAM10 Signaling Is Essential for Maintenance of Long-Lived Multipotent Intestinal Stem Cells (3:25 p.m. PT, Abstract #517) Yu-Hwai Tsai et al. Patch Clamp Recordings Reveal Paracellular (Tight Junction) Ion Channels (3:40 p.m. PT, Abstract #518) Christopher R. Weber et al.

The Clinical Science Plenary Session presentations (May 21, 8 a.m. PT, Room 20d) include:

Effect of Flexible Sigmoidoscopy Screening on Incidence and Mortality From Colorectal Cancer in the PLCO Screening Trial (8:05 a.m. PT, Abstract #588) Robert E. Schoen et al. Modulation of the Brain-Gut Axis After 4-Week Intervention With a Probiotic Fermented Dairy Product (8:27 a.m. PT, Abstract #589) Kirsten Tillisch et al. Screening and Surveillance in Barrett's Esophagus: Does It Make Sense? (8:49 a.m. PT, Abstract #Sp554) David A. Katzka One-Year Effectiveness and Costs of Six Alternative H. pylori Test/Treat and Retest/Retreat Strategies Using Triple, Concomitant or Sequential Drug Regimens in Seven Latin American Sites (SWOG Trial S0701) (9:11 a.m. PT, Abstract #590) Javier Torres et al. Obese Pediatric Patients Have Increased Cardiovascular Disease Risk Comparable to Pediatric Patients With Familial Dyslipidemia (9:33 a.m. PT, Abstract #591) Angela Shannon et al.

Other exciting data will be presented during DDW, including 41 clinical symposia, 12 translational symposia, 11 research symposia, seven state-of-the-art lectures, six distinguished abstract plenary sessions, and other committee-sponsored and special sessions on a range of GI topics. Additionally, the AGA Institute will sponsor four curbside consultant sessions. A total of 11 focused research roundtables and focused clinical updates — breakfast sessions designed to help participants choose the must-see basic science and clinical research abstracts presented during DDW — will occur throughout the meeting.

AGA Academy of Educators Plenary Session We are excited to announce that this year, the AGA will offer a committee-sponsored symposium, AGA Academy of Educators: Teaching and Promoting Scholarship in Education (May 22, 8:30 a.m., Hilton San Diego Bayfront - Indigo E). Discussion topics will include developing successful strategies for teaching, opportunities for scholarship and academic advancement in GI and liver medical education, and successes in and barriers to advancement in medical education. Roundtable discussions including expert teachers and other board members of the academy will follow.

AGA Practitioner Picks AGA Practitioner Picks allow attendees to build their DDW schedule around the most clinically relevant sessions. These picks help community-based gastroenterologists choose the programming that will be the most helpful in day-to-day practice:

Everything You Need to Know about IBS Treatment (May 19, 2:15 p.m. PT, Room 24abc) Clinical Chronic Pancreatitis (May 19, 2:15 p.m. PT, Room 4) Pathogenesis and Diagnosis of Eosinophilic Esophagitis (May 20, 8:30 a.m. PT, Room 30ab) Epidemiology and Management of Eosinophilic Esophagitis (May 20, 2:15 p.m. PT, Room 30cde) Sessile Serrated Polyps - What to Do? (May 20, 2:15 p.m. PT, Room 8) Clinical Science Plenary (May 21, 8 a.m. PT, Room 20d) 2012 Presidential Plenary (May 21, 10 a.m. PT, Room 20d) Advances in the Management of Inflammatory Bowel Disease (May 22, 10:30 a.m., Room 20a) Prebiotics and Probiotics (May 22, 10:30 a.m., Room 3) Managing the Complications of IBD Therapies (May 22, 2:15 p.m. PT, Room 2) Pancreatic Malignancy (May 22, 2:15 p.m. PT, Room 26ab)

AGA Institute-Rome Foundation Lectureship During the sixth annual AGA Institute-Rome Foundation Lectureship (May 20, 10:30 a.m. PT, Room 9), experts will provide a comprehensive overview of Intestinal Permeability in Gastroenterology and its Relevance to Functional GI Disorders and discuss the following topics: Regulation of Intestinal Permeability in Health and Disease Esophageal Permeability: Does It Explain the Symptoms of NERD? Intestinal Permeability: Does It Explain the Symptoms of Functional GI Disorders?

### About the AGA Institute The American Gastroenterological Association is the trusted voice of the GI community. Founded in 1897, the AGA has grown to include 17,000 members from around the globe who are involved in all aspects of the science, practice and advancement of gastroenterology. The AGA Institute administers the practice, research and educational programs of the organization. www.gastro.org.

Like AGA on Facebook: www.facebook.com/AmerGastroAssn. Search for the AGA group on LinkedIn. Follow us on Twitter @AmerGastroAssn. Check out our videos on YouTube: www.youtube.com/AmerGastroAssn.

About DDW DDW is the largest international gathering of physicians, researchers and academics in the fields of gastroenterology, hepatology, endoscopy and gastrointestinal surgery. Jointly sponsored by the American Association for the Study of Liver Diseases, the American Gastroenterological Association Institute, the American Society for Gastrointestinal Endoscopy and the Society for Surgery of the Alimentary Tract, DDW takes place May 19-22�, 2012, at the San Diego Convention Center, CA. The meeting showcases approximately 5,000 abstracts and hundreds of lectures on the latest advances in GI research, medicine and technology. For more information, visit www.ddw.org.

Follow us on Twitter @DDWMeeting; hashtag #DDW12. Like DDW on Facebook: www.facebook.com/DDWMeeting.

ELSE PRESS RELEASES FROM THIS DATE:

Web-based video enhances patient compliance with cancer screening

2012-05-21

Patients who watch an online instructional video are more likely to keep their appointments and arrive prepared for a scheduled colonoscopy than those who do not, according to a study by gastroenterologists at the University of Chicago Medicine. The study, presented at the 2012 annual Digestive Diseases Week meeting in San Diego, CA, found that among patients age 50 to 65 – the primary target for colon cancer screening – those who watched the video were 40 percent less likely to cancel an appointment. That suggests many more cancers could be prevented or detected and ...

ESC Heart Failure Guidelines feature new recommendations on devices, drugs and diagnosis

2012-05-21

New recommendations on devices, drugs and diagnosis in heart failure were launched at the Heart Failure Congress 2012, 19-22 May, in Belgrade, Serbia, and published in the European Heart Journal. The ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 were developed by the European Society of Cardiology (ESC) in collaboration with the Heart Failure Association (HFA) of the ESC. The Congress is the HFA's main annual meeting. An analysis of the most up to date clinical evidence in the field of heart failure by the ESC Guidelines task ...

Oxytocin improves brain function in children with autism

2012-05-21

Preliminary results from an ongoing, large-scale study by Yale School of Medicine researchers shows that oxytocin — a naturally occurring substance produced in the brain and throughout the body— increased brain function in regions that are known to process social information in children and adolescents with autism spectrum disorders (ASD). A Yale Child Study Center research team that includes postdoctoral fellow Ilanit Gordon and Kevin Pelphrey, the Harris Associate Professor of Child Psychiatry and Psychology, will present the results on Saturday, May 19 at 3 p.m. ...

OSA can be managed successfully in the primary care setting

2012-05-21

ATS 2012, SAN FRANCISCO – Patients with moderate-to-severe obstructive sleep apnea (OSA) can be successfully managed in a primary care setting by appropriately trained primary care physicians (PCPs) and community-based nurses, according to Australian researchers. "With the rise in demand and growing waiting lists for sleep physician consultation and laboratory-based sleep services, there has been increasing interest in development of ambulatory strategies for the diagnosis and management of OSA involving home sleep monitoring and auto-titrating continuous positive airway ...

Sleep disordered breathing is associated with an increased risk of cancer mortality

2012-05-21

ATS 2012, SAN FRANCISCO – Sleep disordered breathing (SDB), which is associated with an increased risk of adverse cardiovascular events and psychopathological outcomes, is also associated with an increased risk of cancer mortality, according to a new study. "Recent in vitro and animal studies have shown that repeated episodes of hypoxia (an inadequate supply of oxygen) are associated with accelerated cancer progression," said F. Javier Nieto, MD, PhD, chair of the Department of Population Health Sciences at the University of Wisconsin School of Medicine and Public Health. ...

High prevalence of bone disease in patients referred for pulmonary rehabilitation

2012-05-21

ATS 2012, SAN FRANCISCO – There is a very high prevalence of osteopenia/osteoporosis among male patients with pulmonary disease, according to a new study from researchers in California. "While post-menopausal women are routinely screened for osteoporosis, men are not," said Kathleen Ellstrom, PhD, RN, APRN-BC, Pulmonary Clinical Nurse Specialist and Director of the Pulmonary Rehabilitation Program at the Veterans Administration Loma Linda Healthcare System. "The high prevalence of bone disease we found in male patients referred to our pulmonary rehabilitation program ...

Risk factors for an exacerbation-prone asthma phenotype

2012-05-21

ATS 2012, SAN FRANCISCO – A number of specific risk factors are associated with an exacerbation-prone phenotype of severe asthma, according to a new study from researchers in Sweden. The results will be presented at the ATS 2012 International Conference in San Francisco. "Acute exacerbations are a major source of morbidity and mortality in asthma," said lead author Maciek Kupczyk, MD, PhD, a researcher at the Karolinska Institutet in Stockholm "In children, the costs of asthma care are three times higher in exacerbators as compared to those patients who did not experience ...

Study says children exposed to tobacco smoke face long-term respiratory problems

2012-05-21

ATS 2012, SAN FRANCISCO – For more than three decades, researchers have warned of the potential health risks associated with exposure to environmental tobacco smoke (ETS), especially among children whose parents smoke. Now a new study conducted by researchers from the University of Arizona reports that those health risks persist well beyond childhood, independent of whether or not those individuals end up becoming smokers later in life. The study will be presented at the ATS 2012 International Conference in San Francisco. "This study shows that exposure to parental ...

Treatment of childhood OSA reverses brain abnormalities

2012-05-21

ATS 2012, SAN FRANCISCO - Treatment of obstructive sleep apnea (OSA) in children normalizes disturbances in the neuronal network responsible for attention and executive function, according to a new study. "OSA is known to be associated with deficits in attention, cognition, and executive function," said lead author Ann Halbower, MD, Associate Professor at the Children's Hospital Sleep Center and University of Colorado Denver. "Our study is the first to show that treatment of OSA in children can reverse neuronal brain injury, correlated with improvements in attention ...

Prenatal exposure to pollution especially dangerous for children with asthma

2012-05-21

ATS 2012, SAN FRANCISCO – The link between prenatal exposure to air pollution and childhood lung growth and respiratory ailments has been established by several studies in recent years, and now a new study suggests that these prenatal exposures can be especially serious for children with asthma. The study will be presented at the ATS 2012 International Conference in San Francisco. "In this study, we found that prenatal exposures to airborne particles and the pollutant nitrogen dioxide adversely affect pulmonary function growth among asthmatic children between 6 and ...

AGA presents cutting-edge research during DDW®

ELSE PRESS RELEASES FROM THIS DATE:

LAST 30 PRESS RELEASES: